Conditions: Healthy Pulmonary Disease, Chronic Obstructive
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 35
Healthy volunteers: yes

Brief summary:
This clinical trial is intended to investigate a possible effect of the CYP 2C9 inhibitor fluconazole on the bioavailability of olodaterol

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: BI 1744 intervention 2: Fluconazole
Intervention descriptions: intervention 1: 10 mcg solution for oral inhalation intervention 2: 400 mg capsule

Protocol document: